Sitting on the board at Mount Sinai’s Corinne Goldsmith Dickinson Center for Multiple Sclerosis has made one thing very clear to me: this is not awareness work. This is strategic influence. This is where strategy is shaped, priorities are set, and real impact is decided. Chronically ill leaders belong at the decision-making table, not as symbolic voices, but as key stakeholders..

When people hear “advocacy,” they often picture storytelling: speaking on panels, sharing lived experience, lending a face to a cause. That work matters, but it is not where decisions are made.
Board service is different. At Mount Sinai, my role is not to represent a story, it’s to contribute insight shaped by lived experience to influence decision-making.”
The questions I bring into the room are informed by navigating chronic illness every day, and they are applied at the level of systems, access, and impact.
The questions I bring into the room are informed by navigating chronic illness every day, and they are applied at the level of systems, access, and impact.
Too often, chronic voices are invited in after decisions are formed, asked to react, validate, or humanize outcomes we had no role in shaping.
Board leadership flips that dynamic. It allows chronically ill leaders to:
My leadership doesn’t stop at the board table. Through my professional role in pharmaceutical marketing and my writing with the Chronic Boss Collective, I focus on how chronic illness intersects with work, leadership, and ambition, challenging the idea that professionalism requires concealment of personal health experiences at all costs.
That platform is not a passion project. It is thought leadership. It’s where I explore:
Chronic illness trains leaders in ways no executive training program can:
When chronically ill people sit at decision-making tables, the conversation changes. Priorities shift. Assumptions are challenged. Solutions become more durable because they’re built for real life. This is about better leadership outcomes.
I see my board service and writing as part of a larger leadership arc, one where chronic voices are no longer treated as an afterthought, but an essential piece of collaborative decision-making.
Advocacy is not something I do on the side of my career. It is my leadership practice.
When people with chronic illness help lead, systems work better for everyone.
